1p9u
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1p9u.gif|left|200px]] | [[Image:1p9u.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1p9u", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | + | --> | |
| - | + | {{STRUCTURE_1p9u| PDB=1p9u | SCENE= }} | |
| - | | | + | |
| - | + | ||
| - | }} | + | |
'''Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs''' | '''Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs''' | ||
| Line 30: | Line 27: | ||
[[Category: Wadhwani, P.]] | [[Category: Wadhwani, P.]] | ||
[[Category: Ziebuhr, J.]] | [[Category: Ziebuhr, J.]] | ||
| - | [[Category: | + | [[Category: Coronavirus]] |
| - | [[Category: | + | [[Category: Hcov]] |
| - | [[Category: | + | [[Category: Sars-cov]] |
| - | [[Category: | + | [[Category: Tgev]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 04:51:56 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 01:51, 3 May 2008
Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs
Overview
A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (Mpro, also called 3CLpro), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) Mpro and for an inhibitor complex of porcine coronavirus [transmissible gastroenteritis virus (TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) Mpro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV Mpro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3Cpro inhibitors may be modified to make them useful for treating SARS.
About this Structure
1P9U is a Single protein structure of sequence from Transmissible gastroenteritis virus. Full crystallographic information is available from OCA.
Reference
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs., Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R, Science. 2003 Jun 13;300(5626):1763-7. Epub 2003 May 13. PMID:12746549 Page seeded by OCA on Sat May 3 04:51:56 2008
